drugset / Trial / NCT03238534

Efficacy and Safety Evaluation of Neobianacid® in GERD and EPS

NCT03238534

RandomizedParallel-groupTriple-blindTreatment

Summary

Comparison of Neobianacid® clinical efficacy to omeprazole in relief of heartburn or epigastric pain

Timeline

Start
2017-09-12
Primary completion
2021-09-03
Completion
2021-09-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Omeprazole Other / unclassified 20 mg Oral